In this context, multiple pathways are deregulated in cancer cells, including MAP-kinase, phosphoinositide 3-kinase/protein kinase B (PI3K/AKT), and RAS-extracellular signal-regulated kinase ERK [10]. This evidence concerns the gene AKT1 and cancer.